Tyligand Pharmaceuticals (Suzhou) Limited
1 clinical trials · Sponsor
◉ Watch Tyligand Pharmaceuticals (Suzhou) Limited
| Record | Firm | Date |
|---|---|---|
| A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation (NCT06385925) | Tyligand Pharmaceuticals (Suzhou) Limited | 2024-04-29 |
Track Tyligand Pharmaceuticals (Suzhou) Limited automatically
Every clearance here is in the API, with alerts when new ones post.